Insulin requirements, basal-bolus distribution and basal patterns used by type 1 diabetic patients (T1DM) starting insulin pump therapy (CSII) and after glucose control optimisation

被引：0
作者：
Saigi, I. [1 ]
Tundidor, D. [1 ]
Jordana, L. [1 ]
Maria, M. A. [1 ]
Corcoy, R. [1 ]
Chico, A. [1 ]
机构：
[1] Hosp Santa Creu & Sant Pau, Eduab HSP, Barcelona, Spain
来源：
DIABETOLOGIA | 2010年 / 53卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1006
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Insulin analogues (insulin detemir and insulin aspart) versus traditional human insulins (NPH insulin and regular human insulin) in basal-bolus therapy for patients with Type 1 diabetes
    K. Hermansen
    P. Fontaine
    K. K. Kukolja
    V. Peterkova
    G. Leth
    M.-A. Gall
    Diabetologia, 2004, 47 : 622 - 629
  • [42] Insulin analogues (insulin detemir and insulin aspart) versus traditional human insulins (NPH insulin and regular human insulin) in basal-bolus therapy for patients with Type 1 diabetes
    Hermansen, K
    Fontaine, P
    Kukolja, KK
    Peterkova, V
    Leth, G
    Gall, MA
    DIABETOLOGIA, 2004, 47 (04) : 622 - 629
  • [43] Utilization of postprandial blood glucose (BG) determinations in adolescents with type 1 diabetes (T1DM) using basal:bolus therapy improves glycemic control
    Newmark, Chayim Y.
    White, Neil H.
    DIABETES, 2006, 55 : A95 - A95
  • [44] Italian experience trial for the implementation of insulin glargine in basal-bolus regimen in patients with type 1 diabetes
    Brunetti, P.
    Muggeo, M.
    Cattin, L.
    Arcangeli, A.
    Pozzilli, P.
    Provenzano, V.
    Francesconi, A.
    Calatola, P.
    Santeusanio, F.
    DIABETOLOGIA, 2007, 50 : S394 - S394
  • [45] Basal and Bolus Insulin Dose Changes after Switching Basal Insulin to Insulin Degludec in Patients with Type 1 Diabetes Mellitus: A Pilot Study
    Yoshiyuki Hamamoto
    Sachiko Honjo
    Kanta Fujimoto
    Shinsuke Tokumoto
    Hiroki Ikeda
    Yoshiharu Wada
    Hiroyuki Koshiyama
    Clinical Drug Investigation, 2017, 37 : 845 - 852
  • [46] Basal and Bolus Insulin Dose Changes after Switching Basal Insulin to Insulin Degludec in Patients with Type 1 Diabetes Mellitus: A Pilot Study
    Hamamoto, Yoshiyuki
    Honjo, Sachiko
    Fujimoto, Kanta
    Tokumoto, Shinsuke
    Ikeda, Hiroki
    Wada, Yoshiharu
    Koshiyama, Hiroyuki
    CLINICAL DRUG INVESTIGATION, 2017, 37 (09) : 845 - 852
  • [47] Effect of Exercise on Pharmacokinetics (PK) of Basal Insulin Peglispro (BIL) and Insulin Glargine (GL) in Type 1 Diabetes Mellitus (T1DM) Patients
    Linnebjerg, Helle
    Lam, Eric Chen Quin
    Choi, Siak Leng
    Knadler, Mary P.
    Porksen, Niels
    Sinha, Vikram P.
    Garhyan, Parag
    Klein, Oliver
    Nosek, Leszek
    Heise, Tim
    DIABETES, 2015, 64 : A253 - A253
  • [48] USE OF INSULIN-BOLUS CALCULATOR FREE STYLE INSULINX® IN DIABETES TYPE-1 PATIENTS TREATED WITH BASAL-BOLUS INSULIN REGIMEN
    Delgado, E.
    Tejera, C.
    Bellido, D.
    Morales, F.
    Porca, C.
    Diaz Perez De Madrid, Jose
    DIABETES TECHNOLOGY & THERAPEUTICS, 2015, 17 : A74 - A74
  • [49] Basal insulin plus GLP-1 RA or SGLT2 inhibitor was noninferior to basal-bolus insulin intensification for HbA1c in T2DM
    Boggild, Miranda K.
    Cheung, Angela M.
    ANNALS OF INTERNAL MEDICINE, 2021, 174 (09) : JC106 - JC106
  • [50] Intensification of Insulin Therapy for Type 2 Diabetic Patients in Primary Care: Basal-Bolus Regimen Versus Premix Insulin Analogs When and for whom?
    Mosenzon, Ofri
    Raz, Itamar
    DIABETES CARE, 2013, 36 : S212 - S218
12345